The largest database of trusted experimental protocols

Waters acquity uplc beh c18 column

Manufactured by Waters Corporation
Sourced in United States

The Waters Acquity UPLC BEH C18 column is a high-performance liquid chromatography (HPLC) column designed for the separation and analysis of a wide range of compounds. It features a sub-2-micron particle size and a bonded C18 stationary phase, which provides efficient and high-resolution separations.

Automatically generated - may contain errors

41 protocols using waters acquity uplc beh c18 column

1

Quantifying Flumatinib and Metabolite M1 by UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) equipped with a Waters Acquity UPLC BEH C18 column (2.1 mm × 50 mm, 1.7-μm particle size; Waters Corp., Millipore, Bedford, MA, United States) was used to detect the concentrations of flumatinib and M1. Quantification of the analytes was made by using a Waters XEVO TQS triple quadruple mass spectrometer with a multiple reaction monitoring (MRM) in positive ion mode. The mobile phase was consisted of 0.1% formic acid aqueous solution (A) and acetonitrile (B) at a flow rate of 0.4 mL/min. An elution program of 90% A (0–0.5 min), 90%–10% A (0.5–1.0 min), 10% A (1–1.5 min), 10%–90% A (1.5–1.6 min) and 90% A (1.6–2 min) was performed. The whole elution took 2 min. During the analysis, the temperature of the column and autosampler rack was controlled at 40°C and 10°C, respectively. In addition, optimized parameters for the mass spectra of flumatinib, M1 and dasatinib included: cone voltage were all 10 V, and collision energy was 20 eV, 25 eV, 20 eV, respectively. The monitoring transitions were m/z 563.1 → 463.0, m/z 549.3 → 462.9, and m/z 488.0 → 401.1 for flumatinib, M1 and dasatinib, respectively.
+ Open protocol
+ Expand
2

Metabolomic Profiling by 2D UPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Metabolites separation was performed on a Waters 2D UPLC (Waters, USA) with a Waters ACQUITY UPLC BEH C18 column (1.7 μm, 2.1 mm × 100 mm, Waters, USA), and the column temperature was maintained at 45 °C. The mobile phase in positive ion mode is as follows: 0.1% formic acid solution (50144-50 ml, DIMKA, USA) (A) to 0.1% formic acid methanol solution (B). The mobile phase in negative ion mode is as follows: 10 mM ammonium formate solution (17843-250G, Honeywell Fluka, USA )(A) to 10 mM ammonium formate in 95% methanol (B). The gradient conditions were as follows: 0-1 min, 2% B; 1-9 min, 2%-98% B; 9-12 min, 98% B; 12-12.1 min, 98% B to 2% B; and 12.1-15 min, 2% B. The flow rate was set at 0.35 mL/min, and the injection volume was 5 μL.
Primary and secondary mass spectrometry data were collected by Q Exactive (Thermo Fisher Scientific, USA). The mass spectrometric settings for positive and negative ionization modes were as follows: The full scan range was 70–1050 m/z; spray voltages, 3.80 kV/3.20 kV; capillary temp, 320 °C; Aux gas heater temp, 350 °C; sheath gas flow rate, 40 arbitrary units; Aux gas flow rate, 10 arbitrary units; and runtime, 13 min.
+ Open protocol
+ Expand
3

Quantitative Analysis of Cs-4 Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cs-4 extract, which is a commercial health product, was manufactured and supplied by Royal Medic Group Limited (Hong Kong SAR, China), with the contents of adenine, adenosine, and cordycepin being determined by UPLC-UV quantitative analysis. Briefly, Cs-4 powder was extracted by 25 mL of a mixture of water and ethanol (1:1, v/v). The mixture was sonicated for 30 min and then centrifuged at 3000× g at room temperature. The resultant supernatant was concentrated to 5 mL by rotary evaporation at 60 °C. The concentrated extract was reconstituted to a volume of 25 mL and gave a final concentration of 8 mg/mL. The Cs-4 extract (2 μL) was separated using a Waters ACQUITY UPLC system coupled with a photodiode array detector (Waters Corporation, Milford, MA, USA). A mobile phase consisting of water (solvent A) and acetonitrile (solvent B) was applied for programmed gradient elution with varying concentrations of A and B with time (0 min: 100% A and 0% B, 10 min: 97% A and 3% B, 18 min: 80% A and 20% B, and 21–24 min: 100% A) on a Waters ACQUITY UPLC BEH C18 column (130 Å, 1.7 μm, 2.1 mm × 100 mm) (Waters Corporation, Milford, MA, USA) at a flow rate of 0.25 mL/min and a temperature of 40 °C. The detection wavelength was set at 261 nm. The contents of adenine, adenosine, and cordycepin in the Cs-4 extract fraction were determined using a calibration curve.
+ Open protocol
+ Expand
4

Serum Metabolite Analysis by 2D UPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The serum metabolites were analyzed on Waters 2D UPLC (Waters, Milford, MA, USA) using a Waters 2D UPLC (Waters, USA) linked to a Thermo Fisher Scientific Q-;Exactive mass spectrometer with a heated electrospray ionization (HESI) source and the Xcalibur 2.3 software application (Thermo Fisher Scientific, Waltham, MA, USA). Then, we used Waters ACQUITY UPLC BEH C18 column (1.7 μm, 2.1 mm × 100 mm, Waters, Milford, MA, USA) to complete the chromatographic separation and kept the column temperature constant at 45 °C. In the positive mode, the mobile phase was 0.1% formic acid (A) and acetonitrile (B). The mobile phase included 10 mM ammonium formate (A) and acetonitrile (B) in the negative mode. The mass spectrometric settings for the two ionization modes were given in standard methods [18 (link)]. The identification of metabolites meets the levels published by the Metabolomics Standards Initiative (MSI). [19 (link)]
+ Open protocol
+ Expand
5

UPLC-MS/MS Analysis of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The extracts above were redissolved separately in methanol and passed through a 0.45 µm membrane. A 2 µL of sample was then injected into a Waters ACQUITY UPLC BEH C18 column (2.1 mm × 50 mm, 1.7 µm, 45 °C) connected to a Waters ACQUITY UPLC/Xevo G2 Qtof MS system (Waters Corporation, Milford, MA, USA) equipped with an electrospray source. The column was eluted as follows: 0 min − 95% A + 5% B, 10 min − 0% A + 100% B, where A was water containing 0.1% formic acid and B was acetonitrile. The full scan data were acquired in the positive ion mode from 50 to 1200 Da with a 0.2 s scan time using the following settings: capillary voltage 3.0 kV; de-solvation temperature 350 °C; sample cone voltage 35 V; extraction cone voltage 4 V; source temperature 120 °C; cone gas flow 50 L/h; and desolvation gas flow 800 L/h. The mass spectrometer was calibrated across the mass range of 50–1200 Da using a solution of sodium formate. Data were centroided and m/z values were corrected during acquisition using an external reference consisting of a 0.2 ng/mL solution of leucine enkephalin infused at a flow rate of 5 μL/min via a lockspray interface, generating a reference ion at 556.2771 Da ([M + H]+). The lockspray scan time was set at 0.5 s with an interval of 15 s and data were averaged over three scans.
+ Open protocol
+ Expand
6

UPLC Fingerprinting of Rhodiola Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The UPLC fingerprints of the Rhodiola extracts were analyzed using a Waters Acquity UPLC system consisting of Quaternary Pumps Manager, Sample Manager, Column Manager, Photodiode Detector, and Empower 3 software (Waters Corporation, Milford, MA, United States). The UPLC column (Waters ACQUITY UPLC BEH C18, column; 100 mm × 2.1 mm i.d., 1.8 μm, Waters Corporation, United States) solvent system was gradually increasing concentrations (2.5 to 100% in 14 min) of acetonitrile in water with a flow rate of 0.6 mL/min at 75°C. The injection volume was 2 μL, detection was at 221 nm (phenylethanoids tyrosol and salidroside) and 252 nm (phenylpropanoids). All quantitative results were calculated per dry weight of the extracts.
+ Open protocol
+ Expand
7

UPLC-MS/MS Analysis of Biomolecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
The separation was performed on a Waters ACQUITY UPLC® BEH-C18 column (2.1 mm × 100 mm, 1.7 μm) with the column temperature at 40°. The mobile phases were acetonitrile (A) and 0.1% formic acid in ultra-pure (B) eluting in a gradient program: 0–5.0 min, linear from 5% to 50% A; 5.0–5.2 min, linear from 50% to 90% A; 5.2–7.0 min, and linear from 90% to 5% A; 7.0–8.0 min 5% A for equilibration of the column. The injection volume was 3 μL.
Mass spectrometric detection was performed on a Waters ACQUITY Synapt TOF mass spectrometer (Waters Corp., Manchester, UK) connected with a UPLC system via an ESI interface. The ESI source was operated in a negative ion mode for recording the mass spectra, and leucine-enkephalin was used as the calibration solution. The acquisition parameters for negative modes were: Sampling interval, 0.3 s; mass range recorded m/z, 70 ~ 600; capillary voltage, 3.5 kV; cone voltage, 35 kV; source temperature, 150°C; de-solvation temperature, 500°C; de-solvation gas (N2) flows, 1000 L/h; cone (N2) flows, 50 L/h; collision gas, argon; low energy collision, 6 eV; and high energy collision, 15~45 eV.
+ Open protocol
+ Expand
8

Pharmacokinetic Analysis of Liposomal EF24

Check if the same lab product or an alternative is used in the 5 most similar protocols
For pharmacokinetic analyses, a cohort of 24 mice were administered a single dose of liposomal EF24 (10 mg/kg) intravenously through tail vein. Serum samples (2–4 mice per time point) were collected at 0.25, 1, 2, 3, 4, 6, 8 and 24 h and stored at −80 °C prior to and after use. LC–MS/MS analyses were carried out on a Waters Xevo TQ-S Triple-quad system equipped with a Waters Acquity I-Class UPLC system, an FTN sample manager, binary solvent manager and TUV detector. A Waters Acquity UPLC BEH C18 column (130 Å, 1.7 µm, 2.1 × 100 mm) together with a Waters Acquity UPLC BEH C18 VanGuard pre-column (130 Å, 1.7 µm, 2.1 × 5 mm) was used for separation. Data recording was achieved with the MassLynx 4.1 software package, data processing and quantification was performed with the integrated TargetLynx software using a quadratic regression model. Detailed LC–MS/MS methodology and data quantification is provided as Additional file 1.
+ Open protocol
+ Expand
9

Evaluating QAMS Method Robustness

Check if the same lab product or an alternative is used in the 5 most similar protocols
For further investigation on the robustness of QAMS method, the mixed standard solution should be analyzed under different condition. The RCFs and RTT of the other target peaks to IRS were calculated in different flow rates, column temperatures, and columns using the AVG method and assessed by relative standard deviation (RSD, less than 5%) [39 (link)]. The flow rate was set at 0.3/0.4/0.5 mL/min with temperature maintained at 30/35/40°C, respectively. Waters ACQUITY UPLC® BEH C18 column (2.1 × 50 mm, 1.7 μm), Waters ACQUITY UPLC® BEH C18 column (2.1 × 100 mm, 1.7 μm), SHIMADZU Shim-pack GIST C18-HP column (50 mm × 2.1 mm, 3 μm), SHIMADZU Shim-pack GIST C18-HP column (100 mm × 2.1 mm, 3 μm), and SHIMADZU Shim-pack GIST C18-HP column (150 mm × 2.1 mm, 3 μm) were used to study the effect of different columns.
+ Open protocol
+ Expand
10

UPLC-MS Analysis of Metabolite Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The samples were injected using an autosampler with stack cooler (Open Autosampler UltiMate OAS-3300TXRS, Thermo Fisher Scientific) and eluted through a Waters Acquity UPLC BEH C18 column (130 Å, 2.1 mm × 50 mm, 1.7-µm particles) preceded by a Waters Acquity UPLC BEH C18 VanGuard pre-column, 130 Å, 2.1 mm × 5 mm, 1.7-µm particles) using a Transcend II, LX-2 with UltiMate pumps (Thermo Fisher Scientific). The pressure limits were set at 0.0–1034.0 bar.
The mobile phase consisted of solvent A (97.31% H2O, 1.25% ACN, 1.25% MeOH, and 0.2% FA) and B (2.49% H2O, 48.66% ACN, 48.66% MeOH, and 0.2% FA). The Wash1 solvent was mobile phase A and the Wash2 solvent mix was 25:25:25:25 v/v MeOH/IPA/H20/ACN + 0.2% FA. The gradient (0.25 mL/min) started with 100% A/0% B. After 0.5 min, we applied a gradient ramp to 0% A/100% B over 8.5 min followed by a 0.5-min flow ramp up to 0.9 mL/min and 5 min of 100% B. At 15 min, the column was equilibrated for 5.5 min with 100% A. At 17.5 min, the flow was changed back to 0.25 mL/min over 0.5 min. The total run time was 20.5 min, including 10-min sample run time and 10.5-min column wash and equilibration. The column temperature was maintained at 60.0 °C using a hot pocket column heater and the samples in the autosampler were kept at 4 °C throughout the analysis. The data was acquired in profile mode from 0.20 to 9.80 min.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!